Human Visceral Adipose Tissue and the Plasminogen Activator Inhibitor Type 1

International Journal of Obesity - United Kingdom
doi 10.1038/sj.ijo.0803650
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Highly Stable Plasminogen Activator Inhibitor Type One (VLHL PAI-1) Protects Fibrin Clots From Tissue Plasminogen Activator-Mediated Fibrinolysis

International Journal of Molecular Medicine
MedicineGenetics
2007English

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced in Vitro Cerebral Angiogenesis

PLoS ONE
Multidisciplinary
2012English

The Tissue-Type Plasminogen Activator Story

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2009English

4766075 Human Tissue Plasminogen Activator

Biotechnology Advances
Applied MicrobiologyBiotechnologyBioengineering
1989English

Changes in Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Sepsis With Organ Failure.

Nihon Kyukyu Igakukai Zasshi
1994English

Interaction of Single-Chain Urokinase and Plasminogen Activator Inhibitor Type 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Prognostic Value of Tissue-Type Plasminogen Activator (tPA) and Its Complex With the Type-1 Inhibitor (PAI-1) in Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1999English

Retraction: The Effects of Residual Platelets in Plasma on Plasminogen Activator Inhibitor-1 and Plasminogen Activator Inhibitor-1-Related Assays

PLoS ONE
Multidisciplinary
2018English

Thrombin and Plasmin Generation in Patients With Plasminogen or Plasminogen Activator Inhibitor Type 1 Deficiency

Haemophilia
MedicineGeneticsHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy